SL
Sean Laaman Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
22
Avg Return
Past Year
Past Year
10%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
77.3%
Neutral
18.2%
Negative
4.5%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Health Information Services
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Equal-Weight
Downgraded
| $204 |
22%
upside
| 4 | +18% |
0
%
| 8 Jan ‘26 11 hours ago |
|
|
|
Equal-Weight
Downgraded
| $48 |
9%
upside
| 5 | +2% |
0
%
| 8 Jan ‘26 11 hours ago |
|
|
|
Overweight
Initiated
| $96 |
30%
upside
| 1 | +1.2% |
0
%
| 6 Jan ‘26 2 days ago |
|
|
|
Equal-Weight
Maintained
| $12 |
25%
upside
| 2 | – |
–
| 18 Dec ‘25 21 days ago |
|
|
|
Overweight
Initiated
| $20 |
56%
upside
| 1 | +12% |
0
%
| 5 Dec ‘25 1 month ago |
|
|
|
Overweight
Initiated
| $34 |
103%
upside
| 1 | +26% |
0
%
| 21 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $115 |
46%
upside
| 3 | +16% |
0
%
| 30 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $304 |
21%
upside
| 1 | -7.4% |
0
%
| 21 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $383 |
19%
upside
| 2 | +13% |
0
%
| 20 Oct ‘25 2 months ago |
|
|
|
Underweight
Assumed
| $1.50 |
14%
downside
| 1 | -12% |
0
%
| 7 Mar ‘25 10 months ago |
|
|
|
Overweight
Assumed
| $67 |
9%
downside
| 1 | +27% |
0
%
| 14 Feb ‘25 10 months ago |
|